Previous studies have shown that serum haptoglobin (Hp), containing four N-glycosylation sites is a reporter molecule for aberrant glycosylation in tumorigenesis, including hepatocarcinogenesis and could serve as a highly specific biomarker for HCC [189]. The gene discussed is HP; the disease is hepatocellular carcinoma.